ISPOR 2025 is now in about two weeks and in this second post about sessions to look for, I’ll talk about regulations and pricing (this is part of a series: last week, I wrote about Modelling; next week, I will write about AI). IRA letters on a pile of scientific papers with a view of an American city at night ...
Many headlines stated today that UK wants to tax pharmaceutical companies again in order to contribute to a pooled fund against antimicrobial resistance (AMR). The proposed ‘pay or play’ mechanism is a bit more subtle than that. The report ( full text here) is also suggesting other financing mechanisms (including the improvement of existing ones) as well as describing potential non-financial measures to reduce these resistances in the first place. Actually, financial measures occupy only about 6% of the report. But headlines need to be catchy. Let’s see a broader picture on tackling antibiotic resistance … ...